<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Molecular mechanisms specific to <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> have been poorly characterized </plain></SENT>
<SENT sid="1" pm="."><plain>Using comparative whole-genome expression profiling, we observed differential expression of epiregulin (EREG) in mouse models of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated, but not <z:hpo ids='HP_0003745'>sporadic</z:hpo>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Similarly, EREG expression was significantly upregulated in cohorts of patients with <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated fibroblasts were identified as a major source of EREG in <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Functional studies showed that Ereg-deficient mice, although more prone to <z:hpo ids='HP_0002583'>colitis</z:hpo>, were strongly protected from <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Serial endoscopic studies revealed that EREG promoted <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> rather than initiation </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, we demonstrated that fibroblast-derived EREG requires ERK activation to induce proliferation of intestinal epithelial cells (IEC) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>To demonstrate the functional relevance of EREG-producing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated fibroblasts, we developed a novel system for adoptive transfer of these cells via mini-endoscopic local injection </plain></SENT>
<SENT sid="8" pm="."><plain>It was found that transfer of EREG-producing, but not Ereg-deficient, fibroblasts from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> significantly augmented growth of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:hpo ids='HP_0002664'>neoplasms</z:hpo> in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, our data indicate that EREG and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated fibroblasts play a crucial role in controlling <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>